MedTrace Logo

Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers

NCT01529320 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2016-05-12

No results posted yet for this study

Summary

Determine the mean time to itch relief from the start of treatment with topic methylprednisolone aceponate.

Conditions

  • Allergic Contact Eczema

Interventions

DRUG

Adventan® (methylprednisolone aceponate 0,1%)

Doses: 1/4 FTU (Finger Tip Unit) during 5 days (Day 7-Day 11). Procedure: Patch Test (Nickel sulphate 5%) during 2 days (Day 0- Day 2.

Sponsors & Collaborators

  • Adknoma Health Research

    collaborator INDUSTRY

  • Bayer

    collaborator INDUSTRY

  • Fundacion IMIM

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01529320 on ClinicalTrials.gov